Go To Global Site
Welcome to UCB in the United States

Nov

04

Recognizing Non-Radiographic Axial Spondyloarthritis Patients

As we join the rheumatology community at ACR Convergence 2020, Head of U.S. Medical Immunology, Dr. Jeff Stark, shares the importance of a new diagnostic code for nr-axSpA in helping to improve the patient journey and to lead to more innovation. Read more.

Oct

31

Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

Oct

29

Looking to The Future: How UCB is Supporting Dermatology Patients Now and Tomorrow

Read more from UCB's Head of U.S. Immunology, Camille Lee, who shares how UCB is supporting dermatology patients now throughout the pandemic and in the future. 

Oct

29

UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology

Oct

27

UCB+ as an Advocate for All

While many have felt the impact of the current environment, the members of UCB+, our employee resource group for the LGBTQ+ community and allies in UCB, recognize this time as an opportunity to lead. In commemoration of the 50th Atlanta Pride celebration, we’re pleased to share a little more about UCB+. 

Oct

26

Finding Success as a Scientist: Women and Diversity in Science with Cierra Spencer

UCB is proud to have scientists like Cierra Spencer, PhD, who are driven and share our vision to create an environment that encourages innovation, expertise, and #diversity. Cierra shares the story of how she found her passion for the pharmaceutical industry and some advice for other women in science as they pursue their career. 

Oct

23

UCB Women’s Health Fellowship Program

As the nationwide shortage of rheumatologists continues, UCB would like to encourage the development of future Thought Leaders in key areas of unmet need. By creating additional training opportunities for current rheumatology fellows, UCB hopes specifically to increase women’s health expertise in the rheumatology community. This program will support the year-long training of up to three rheumatology fellows ($100,000 each) with a specialized focus on women’s health-related issues, specifically in the context of inflammatory diseases.  

Oct

22

The Path is Not Always Linear

UCB’s Iram Hasan, Senior Manager, Regulatory Affairs, understands the importance of being flexible and attributes the milestones in her career path to this mentality. Read more from Iram on how keeping an open mind led her to launching UCB’s first PharmD fellowship program in Global Regulatory Affairs (GRA).

Oct

21

New approaches to STEM support during COVID-19

UCB is committed to investing in STEM education across the U.S. because we recognize the important role of the biopharmaceutical industry to inspire and develop a sustainable and diverse STEM workforce now and in the future. With this, we also know there are many challenges teachers and students may face when developing STEM programs, especially during a pandemic. As such, UCB has looked for different approaches to expand our investment to better support them. 

Oct

13

Celebrating Hispanic Heritage Month with New Employee Resource Group RAIZ

As UCB continues to grow as a global company, the diversity and inclusivity of the culture continues to expand as well by creating new opportunities of connection both within and beyond UCB’s employee community. In commemoration of Hispanic Heritage Month, UCB is proud to offer a new employee resource group (ERG), RAIZ, dedicated to the many Hispanic and Latino UCB colleagues.